NASDAQ:AVAH

Aveanna Healthcare (AVAH) Stock Price, News & Analysis

Aveanna Healthcare logo
$10.96 +0.26 (+2.42%)
As of 11:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.

About Aveanna Healthcare Stock (NASDAQ:AVAH)

Advanced

Key Stats

Today's Range
$10.65
▼
$10.98
50-Day Range
$10.70
▼
$14.38
52-Week Range
$5.93
▼
$14.71
Volume
232,688 shs
Average Volume
2.05 million shs
Market Capitalization
$2.39 billion
P/E Ratio
7.97
Dividend Yield
N/A
Price Target
$14.25
Consensus Rating
Moderate Buy

Company Overview

Aveanna Healthcare Holdings Inc. is a U.S. provider of home-based healthcare services for children and adults with complex medical needs. Its services include private-duty nursing and personal care, home health nursing and therapy, and hospice care, helping patients receive support in their homes and communities.

The company also provides medical supplies and related services, including products used for enteral nutrition. Aveanna serves patients and families across multiple states through a network of clinicians, caregivers, and local operations.

Aveanna was formed in 2017 through the combination of several healthcare businesses, including Epic Health Services and PSA Healthcare. The company’s operations have since grown to span pediatric and adult care settings.

AI Generated. May Contain Errors.

Aveanna Healthcare Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
97th Percentile Overall Score

AVAH MarketRank™: 
4.829576690485 of 5 stars

Aveanna Healthcare scored higher than 97% of companies evaluated by MarketBeat, and ranked 9th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Aveanna Healthcare has received a consensus rating of Moderate Buy. The company's average rating score is 2.73, and is based on 1 strong buy rating, 6 buy ratings, 4 hold ratings, and no sell ratings.

  • Upside Potential

    Aveanna Healthcare has a consensus price target of $14.25, representing about 33.2% upside from its current price of $10.70.

  • Amount of Analyst Coverage

    Aveanna Healthcare has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Aveanna Healthcare's stock forecast and price target.
  • Earnings Growth

    Earnings for Aveanna Healthcare are expected to grow by 14.67% in the coming year, from $0.75 to $0.86 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Aveanna Healthcare is 7.81, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.10.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Aveanna Healthcare is 7.81, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 33.21.

  • Price to Earnings Growth Ratio

    Aveanna Healthcare has a PEG Ratio of 0.72. PEG Ratios below 1 indicate that a company could be undervalued.

  • Price to Book Value per Share Ratio

    Aveanna Healthcare has a P/B Ratio of 6.95. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Percentage of Shares Shorted

    3.51% of the float of Aveanna Healthcare has been sold short.
  • Short Interest Ratio / Days to Cover

    Aveanna Healthcare has a short interest ratio ("days to cover") of 3.97, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Aveanna Healthcare has recently increased by 35.95%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Aveanna Healthcare does not currently pay a dividend.

  • Dividend Growth

    Aveanna Healthcare does not have a long track record of dividend growth.

  • News Sentiment

    Aveanna Healthcare has a news sentiment score of 0.70. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.39 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 8 news articles for Aveanna Healthcare this week, compared to 5 articles on an average week.
  • MarketBeat Follows

    7 people have added Aveanna Healthcare to their MarketBeat watchlist in the last 30 days. This is an increase of 250% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Aveanna Healthcare insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $558,509,932.00 in company stock.

  • Percentage Held by Insiders

    5.30% of the stock of Aveanna Healthcare is held by insiders.

  • Percentage Held by Institutions

    87.96% of the stock of Aveanna Healthcare is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Aveanna Healthcare's insider trading history.
Receive AVAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aveanna Healthcare and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

AVAH Stock News Headlines

UBS Sticks to Its Hold Rating for Aveanna Healthcare Holdings (AVAH)
Your free book is about to disappear
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
Healthcare devices and stock market data overlay, highlighting volatility in medical equipment sector investments.
Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch (AVAH)
As Medicare for All regains attention after Democrats' 2026 midterm wins, Addus HomeCare, Aveanna Healthcare and National Vision stand out as stocks with Medicaid reimbursement upside.
See More Headlines

AVAH Stock Analysis - Frequently Asked Questions

Aveanna Healthcare's stock was trading at $8.17 on January 1st, 2026. Since then, AVAH shares have increased by 31.0% and is now trading at $10.70.

Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) issued its earnings results on Thursday, November, 12th. The company reported $0.23 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.21 by $0.02. The business earned $695.54 million during the quarter, compared to the consensus estimate of $679.48 million. Aveanna Healthcare had a net margin of 11.44% and a trailing twelve-month return on equity of 63.61%.
Read the conference call transcript
.

Aveanna Healthcare (AVAH) raised $478 million in an initial public offering (IPO) on Thursday, April 29th 2021. The company issued 38,200,000 shares at $12.00-$13.00 per share. Barclays, J.P. Morgan, BMO Capital Markets and Credit Suisse served as the underwriters for the IPO and BofA Securities, Deutsche Bank Securities, Jefferies, RBC Capital Markets, Truist Securities, Raymond James, Stephens Inc., Drexel Hamilton and Siebert Williams Shank were co-managers.

Top institutional shareholders of Aveanna Healthcare include Marshall Wace LLP (2.21%), Boston Partners (1.39%), State Street Corp (1.07%) and Algert Global LLC (0.75%). Insiders that own company stock include Robert M Williams Jr, Paul R Vigano, JH Whitney Equity Partners V, Jeff Shaner, Rodney D Windley, Edwin C Reisz, Matthew Buckhalter, Deborah Stewart and Patrick A Cunningham.
View institutional ownership trends
.

Shares of AVAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Aveanna Healthcare investors own include Micron Technology (MU), Advanced Micro Devices (AMD), Energy Transfer (ET), NVIDIA (NVDA), Broadcom (AVGO), Tesla (TSLA) and Lockheed Martin (LMT).

Company Calendar

Last Earnings
11/12/2026
Today
11/20/2026
Fiscal Year End
12/31/2026

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Services
Current Symbol
NASDAQ:AVAH
CIK
1832332
Fax
N/A
Employees
35,500
Year Founded
2017

Price Target and Rating

High Price Target
$16.00
Low Price Target
$11.00
Potential Upside/Downside
+30.4%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.73
Research Coverage
11 Analysts

Profitability

EPS (Trailing Twelve Months)
$1.37
Trailing P/E Ratio
7.95
Forward P/E Ratio
12.71
P/E Growth
0.72
Net Income
$225.03 million
Net Margins
11.44%
Pretax Margin
7.68%
Return on Equity
63.61%
Return on Assets
8.07%

Debt

Debt-to-Equity Ratio
3.80
Current Ratio
1.23
Quick Ratio
1.23

Sales & Book Value

Annual Sales
$2.43 billion
Price / Sales
0.98
Cash Flow
$0.69 per share
Price / Cash Flow
15.73
Book Value
$1.54 per share
Price / Book
7.10

Miscellaneous

Outstanding Shares
218,410,000
Free Float
206,834,000
Market Cap
$2.39 billion
Optionable
Optionable
Beta
2.03

Social Links

7 Stocks That Could Lead the Next Market Boom Cover

Tesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom.

Get This Free Report

This page (NASDAQ:AVAH) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners